anthrax/headache

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

15 rezilta yo

Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To assess the safety of a licensed anthrax vaccine given to nearly 400,000 US military personnel, reports of adverse events (AEs) submitted to the Vaccine Adverse Event Reporting System (VAERS) were reviewed and evaluated medically. METHODS The Anthrax Vaccine Expert Committee (AVEC), a

Two rare presentations of fatal anthrax: meningeal and intestinal.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Anthrax is an ancient disease of animals and men, caused by Bacillus anthracis. The diagnosis of cutaneous infection is relatively easy, but other clinical forms might escape recognition. We present two rare and fatal forms of anthrax: meningeal in a 33-year-old male shepherd and intestinal in a

Cutaneous anthrax--a report of ten cases.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The clinical features of ten cases of cutaneous anthrax are reported. Six males and four females were affected. Their ages ranged from one and a half year to sixty years. The average incubation period was 8 days. Fever and headache were common systemic manifestations. Pruritus and ulcer with

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND We report the results of a phase I dose escalation, safety and immunogenicity trial of a new recombinant protective antigen (rPA102) anthrax vaccine. METHODS Hundred healthy volunteers were randomized in a 4:1 ratio to receive intramuscular doses of rPA102 in the following formulations:

Bioterrorism. DOD retreats on plan for anthrax vaccine.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Anthrax bacterium, once the deadly scourge of goat-hair workers, has become the bane of the U.S. defense establishment. Without infecting a single soldier, it has created a logistical headache for the Pentagon, as military contractors have fallen far short of supplying a vaccine that will protect

Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Inhalational anthrax (IA) is a rapidly progressive disease that frequently results in sepsis and death, and prompt recognition is critical. To distinguish IA from other causes of acute respiratory illness, patients who had IA were compared with patients in an ambulatory clinic who had influenza-like

Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

After inhalational anthrax was diagnosed in a Connecticut woman on November 20, 2001, postexposure prophylaxis was recommended for postal workers at the regional mail facility serving the patient's area. Although environmental testing at the facility yielded negative results, subsequent testing

Outbreak of human anthrax in Ramabhadrapuram village of Chittoor district in Andhra Pradesh.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Thirty human anthrax cases were reported from Ramabhadrapuram village of Chittoor district in Andhra Pradesh during November-December, 1989. These cases occurred following an epizootic of anthrax among cattle and sheep of the village and ingestion of contaminated meat by the villagers. The overall

Clinical aspects, diagnosis and treatment of anthrax

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

There are three clinical presentations of anthrax in humans: cutaneous (>95% of cases), orogastric and inhalational. The infectious form, the spore, enters the body and is thought to germinate within macrophages either at the site of inoculation (cutaneous or orogastric) or in the regional lymph

Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The use of anthrax as a weapon of biological terrorism has moved from theory to reality in recent weeks. Following processing of a letter containing anthrax spores that had been mailed to a US senator, 5 cases of inhalational anthrax have occurred among postal workers employed at a major postal

[Anthrax meningoencephalitis: a case report and review of Turkish literature].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The incidence of anthrax is decreasing in Turkey, however, it is still endemic in some regions of the country. Although central nervous system involvement is rare in cases with anthrax, high mortality rates are significant. Here, we report a 46-years old woman who was anthrax meningoencephalitis.

Identifying Meningitis During an Anthrax Mass Casualty Incident: Systematic Review of Systemic Anthrax Since 1880.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Bacillus anthracis, the causative agent of anthrax, is a potential bioterrorism agent. Anthrax meningitis is a common manifestation of B. anthracis infection, has high mortality, and requires more aggressive treatment than anthrax without meningitis. Its rapid identification and treatment are

A 43-year-old colonel with chills, diaphoresis, and headache.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The objectives were to illustrate the ease with which one might attribute concomitant or subsequent illness to an exposure such as the anthrax vaccine and to demonstrate an approach that keeps the significance of such exposures in appropriate perspective. A 43-year-old, active duty, Army officer

Neurological aspects of biological and chemical terrorism: a review for neurologists.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The Centers for Disease Control and Prevention urge physicians to become familiar with chemical and biological weapons. Preparedness among neurologists is especially important because several of these agents affect the nervous system. This article reviews 4 agents that have a history of military or

Neurobiological weapons.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Biological warfare is a potential threat on the battlefield and in daily life. It is vital for neurologists and other health care practitioners to be familiar with biological and toxic agents that target the nervous system. most illnesses caused by biological warfare agents are not commonly

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye